NCT01157234
Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients
See it on ClinicalTrials.gov ↗30 people
30%
70%
9 womenmiddle line = equal numbers21 men
- Phase
- PHASE4
- Paid for by
- University of Florida
- Finished
- 2014-07
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 49.7 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 56.7% · Black / African American 43.3% · American Indian / Alaska Native 0% · Asian 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0% · Not reported 0%
Women left out
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“…diac failure, sick sinus syndrome (unless permanent pacemaker in place), severe hepatic impairment( defined as elevation of aspartamine aminotransferase , alanine aminotransferase, or bilirubin levels to three times upper limit of normal re…”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“…eart rate (HR) \<60 beats per minute , heart block \> 1st degree, decompensated cardiac failure, sick sinus syndrome (unless permanent pacemaker in place), severe hepatic impairment( defined as elevation of aspartamine aminotransferase , al…”
Study titles and rules are shown in their original English.